Welcome to our dedicated page for TILRAY BRANDS news (Ticker: TLRY), a resource for investors and traders seeking the latest updates and insights on TILRAY BRANDS stock.
Tilray Brands Inc. (TLRY) maintains a dynamic presence in global cannabis markets through its medical research initiatives and consumer product innovations. This resource provides investors and industry observers with centralized access to verified corporate announcements, regulatory developments, and market analysis.
Users will find updates spanning earnings reports, international expansion efforts, and product portfolio enhancements, including developments in cannabis-infused wellness solutions. The curated selection enables stakeholders to track operational milestones across Tilray's pharmaceutical-grade production facilities and lifestyle brand divisions.
All content undergoes strict verification to ensure alignment with financial disclosure standards and industry regulations. Regular updates reflect Tilray's position as a GMP-certified producer serving medical markets in 20+ countries while expanding recreational offerings in emerging markets.
Bookmark this page for streamlined monitoring of Tilray's strategic initiatives, quality control advancements, and responses to evolving cannabis legislation worldwide.
Charlotte's Web Holdings reported Q3 2024 financial results with revenue of $12.6 million, down from $14.3 million in Q3 2023. The company saw a net loss of $5.8 million ($0.04 per share), improved from a $15.2 million loss in Q3 2023. Notable developments include expansion into Walmart with CBD topicals in 827 stores, launch of new Functional Mushroom Gummies, and partnership with Tilray for Canadian market entry. SG&A expenses decreased 36.2% to $12.7 million, reflecting cost reduction initiatives. The company maintains $24.6 million in cash and $33.5 million in working capital as of September 30, 2024.
Tilray Medical has launched its first commercial German-grown medical cannabis products from its Aphria RX facility under a newly issued cultivation license. The company received Germany's first medical cannabis cultivation license under MedCanG on July 15, 2024, allowing them to cultivate and manufacture a broad range of medical cannabis products. The strains selected for cultivation at the indoor facility are derived from top-performing varieties popular with patients in Canada. This development strengthens Tilray's position in German medical cannabis cultivation, production, and distribution.
10 Barrel Brewing, a subsidiary of Tilray Brands (NASDAQ: TLRY), announces its 13th Annual Pray for Snow Party, a free community event scheduled for November 16, 2024, in Bend, Oregon. The winter celebration will run from 5-10 p.m., featuring live music, giveaways, and the premiere of the 'Beer Lodge' film. Event highlights include free board waxing by Powderhouse, local industry vendors, a Jerry costume contest, and various winter sports-related activities. The 'Beer Lodge' film, documenting 40 days of winter sports activities in McCall, Idaho, will premiere at the event before its digital release on The Bomb Hole on November 18, 2024.
Breckenridge Distillery, a subsidiary of Tilray Brands (NASDAQ: TLRY), has launched its new Candy Cane Vodka for the holiday season. The 80 proof (40% ABV) vodka features peppermint and white chocolate bark flavors, available in 750ml and 50ml bottles nationwide. This release joins Breckenridge's existing flavored vodka portfolio, which includes Pear, Chili Chile, and Espresso variants. The product features festive red-striped bottles designed to enhance holiday tablescapes.
SweetWater Brewing Company, Atlanta's leading craft brewer and a Tilray Brands subsidiary, has announced the lineup for its 20th Anniversary 420 Fest, scheduled for April 18-20, 2025, at Atlanta's Historic Pullman Yards. The festival will feature headliners The Revivalists, Marcus King, Greensky Bluegrass, Drive-By Truckers, and Cypress Hill.
The event combines music, craft beer, art, and environmental initiatives. Festival highlights include interactive art installations, a Craft Beer Village featuring multiple breweries, family-friendly spaces, and returning attractions like SweetWater's Fishing Camp. The festival emphasizes sustainability through green energy credits, a partnership with Waterkeeper Alliance ($10 per ticket), bike valet services, and comprehensive recycling programs.
Tilray Brands (NASDAQ: TLRY) has launched 'Men's Health on Tap', a new podcast series hosted by Dr. John P. Sfakianos and Dr. Steven A. Kaplan from the Icahn School of Medicine. The podcast aims to address men's health topics, including mental health, prostate cancer, and wellness. This initiative is part of Tilray's broader men's health campaign, which includes collaborations with Montauk Brewing and Blue Point Brewery. The company is also supporting Movember through Blue Point Brewing's special 'Big Mo' beer release and Breckenridge Distillery's partnership with Flaviar for the 'Dad's Stash Whiskey' launch, supporting Fight Colorectal Cancer.
Tilray Medical has announced final results from a clinical study on oral cannabis extract for Chemotherapy-Induced Nausea and Vomiting (CINV). The randomized, placebo-controlled trial involved 147 participants from 2016 to 2022, testing capsules containing 2.5mg THC and 2.5mg CBD versus placebo. The study showed significant improvements, with complete response rates increasing from 8% (placebo) to 24% (THC:CBD). While demonstrating reduced nausea and fewer daily vomits, some side effects were observed, including sedation (18% vs 7%), dizziness (10% vs 0%), and anxiety (4% vs 1%).
Breckenridge Brewery, a Tilray Brands (NASDAQ: TLRY) subsidiary, has partnered with the University of Colorado Athletics to release a -edition version of their Juice Drop Hazy IPA in 19.2oz cans. The co-branded packaging features the CU Buffaloes logo alongside Breckenridge's branding, targeting both beer enthusiasts and Buffs supporters. The collaboration, developed with Buffalo Sports Properties and CLC, builds on Breckenridge's four-year relationship as the Buffs' craft beer partner. The special edition will be available at select retailers across Colorado, particularly in Boulder and surrounding areas.
Breckenridge Distillery, a subsidiary of Tilray Brands (NASDAQ: TLRY), has partnered with Flaviar to release Dad's Stash Whiskey, a -edition whiskey supporting No-Shave November and raising funds for Fight Colorectal Cancer (Fight CRC). The 86-proof whiskey features notes of black walnut, leather, tobacco, chocolate, and vanilla, with a creamy caramel and oak finish. Available exclusively on Flaviar.com and Caskers.com for $44.99, with all sales proceeds being donated to No-Shave November to benefit Fight CRC's cancer research, education, and prevention initiatives.
Blue Point Brewing Company, a subsidiary of Tilray Brands (NASDAQ: TLRY and TSX: TLRY), is launching its men's health awareness campaign for Movember. The brewery is releasing a special edition of its classic double IPA, Big Mo, with a portion of proceeds going to the Movember Foundation.
The campaign includes several events at Blue Point's BrewPub in Patchogue, New York:
- Nov. 1: Movember Shave-Off
- Weekly progress picture opportunities
- Nov. 30: Movember Wrap Party featuring live performance by Easy Chief
Blue Point is also hosting its 20th Annual Cask Ales Festival on Nov. 2, 2024. The brewery encourages community participation in the 'Grow a Mo' program through the Movember Foundation App to raise awareness for men's health issues, including mental health, prostate cancer, and testicular cancer.
FAQ
What is the current stock price of TILRAY BRANDS (TLRY)?
What is the market cap of TILRAY BRANDS (TLRY)?
